"MUST READ" Alright $IMMB Investors and Future Investors

New Post Public Reply Private Reply Replies (0) Message Board

Feb 5, 2013 at 11:08 PM

"MUST READ" Alright $IMMB Investors and Future Investors here is why I just posted a world of info on HIV/AIDS, To show everyone we are sitting on an ABSOLUTE LIFE CHANGER.

Amazing Website >> http://www.immunotechlab.com/

As you can see the market here is wide open for growth and by 2018 will consist of a $21 Billion Industry with a steady growth of 7% per annum. More IMPORTANTLY we are in an transition period where MANY current PATENTS will EXPIRE, leaving the door wide open for IMMB!

Why is that important to IMMB, there is simply room for Competitors and definite interest for MERGERS/ACQUISITIONS of smaller cap companies. Something in this economy that is happening everyday.

Well here is my take as to WHY you should BUY IMMB....

IMMB currently carries a HV/AIDS PATENT valued at over $5 Million >> http://imagehost.vendio.com/a/8709739/view/Patent.png

So we are in the market. Now we need a game plan, well Dr. Harry Zhabilov worked his ass off for many years using his amazing scientific skills to create a patent... IMMB then realizes they can tap into a Billion Dollar Market with his Patents which for the record we have not one but 4 Patents. ...Mr.Zhabilov is an amazing Doctor....but he can't do it on his own so on October of 2012 he makes an even more Brilliant move than his Patent Creation, HE SIGNS a contract with Mr. Bo Linton and appointed him to be part of the Board of Directors .
Well for the people who don't know BO LINTON he has a habit of taking the companies he is involved with to the BIG BOARDS NYSE/NASDAQ)...His last one being MAGNEGAS whom just recently rang the closing bell!

As of February/2013 IMMB made another BIG move, they appointed Mr. Valentin Dimitrov to the board of directors of the company. Mr. Dimitrov is a CEO of M.T. Rose Corporation also Mr. Dimitrov is one of the owners of the second largest chemical plant in Bulgaria, Europe.

So now we have a growing Board with TOP notch Members whom carry HUGE connections.

Still with me, well on November 2012 a HUGE NEWS RELEASE Link Provided >> http://www.otcmarkets.com/stock/IMMB/news
Immunotech Laboratories Inc. Announces Breakthrough Results for HIV and AIDS Treatment for Terminal Salvage Patients

Followed by a much BIGGER News RELEASE JAN/2013 Link Provided >> http://www.otcmarkets.com/stock/IMMB/news
Immunotech Laboratories Announces LOI With International Bio-Tech Partner For USA Clinical Trials Funding Of Patented HIV Medicines

Which in turn led to THE BIGGEST ONE TO DATE FEB/2013 Link Provided >> Immunotech Laboratories (IMMB) Patented "IPF" Technology A Serious Contender In The Race For HIV & Cancer Cures

If you are still with me you are now adding everything up and saying to yourself HOLY SH*T, We are OFFICIALLY INVOLVED in THAT COVETED BILLION DOLLAR MARKET....and you should be saying IMMB is the MOST UNDERVALUED MEDICAL SCIENCE COMPANY in the OTC soon to be NASDAQ and or NYSE...

From the last PR and in the words of MR.BO LINTON (read BOLD)>>
Mr. Linton further commented the company recently received an initial inquiry for a significant order of the company's patented HIV vaccine by an International associate for use as an "Experimental Drug". If confirmed the initial order would be in excess of several Million Dollars. This would expand the company's operations from Research & Development to a Bio-Pharma manufacturing company . In Africa, where approved experimental treatments are permitted, there are approximately 30 Million HIV/AIDS patients alone.

Now that you are seeing what I am seeing I will show you the KICKER >>

CURRENT SHARE STRUCTURE
OUTSTANDING SHARES 60,500,000 give or take a handful
FLOAT 1 MILLION YES, MILLION (give or take a handful)CONFIRMED Jan.31/2013 in video interview with MR. LINTON (link provided ) >> http://www.otcmarkets.com/stock/IMMB/news
AUTHORIZED 150,000,000

Want More, I have more >>
INSIDERS HOLDINGS 98% of O/S Here is the PROOF >>
Name of Shareholder Number of Shares
Harry Zhabilov 24,895,646 41.11
Ara Ghanime 24,895,646 41.11
Dow Jones Link 2,773,500 4.58
Allie Chang 600,000 1.0
Paul Felizian 600,000 1.0
Lord George Equities 5,400,000 9.0
Joseph Pittera 250,000 0.41
Harout Tovmasyan 151,000 0.25
Elie Sakayan 50,000 0.08
Hagop Parseghian 600,000 1.0
Others 339,896 0.46

So there you have it!

PS since last Wednesday in case you missed it we have seen LESS than 400,000 Shares TRADED or for the most part BOUGHT and we are up from .06 to .35 with MAJOR NEWS PENDING....with that said we have seen MAJOR BIDS UNTOUCHED where investors could have taken HUGE PERCENTAGE GAINS and SIMPLY REFUSED to knowing where IMMB is heading SHORT TERM and or LONG TERM!

Good LUCK and REMEMBER only use this as a reference an never spend more than you are willing to lose.

Your Friend Cheeky!

PSS there is more to IMMB than HIV/AIDS Please go to WEBSITE and absorb as much as you can, They are diversified to say the least...link provided above!

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aurora Innovation Faces Legal Heat Amid Delays

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Evaluating GLP-1 Telehealth? Key Questions to Consider

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Paris Baguette Pioneers Drive-Thru in Oklahoma

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Mynd.ai Alters ADS Ratio Affecting Share Dynamics

Analyzing Mynd.ai's ADS Ratio Tweak When Mynd.ai decides to shake things up with the American Depositary Shares (ADS) ratio, it's like they're throwing a curveball straight at Wall Street. Listen up, this isn't just a deck shuffle—it's a fundamental tweak that could play a big role in the stock’s perceived value. Starting December 7, 2027, one ADS will leap from...

James Hardie Joins S&P MidCap 400; Roku Acquired

A Shift in the MidCap 400: What's Up? Well, wouldn’t you know it, James Hardie Industries is making waves as it steps into the S&P MidCap 400. This move happens because Fox Corp. has nabbed Roku in a deal worthy of some popcorn. Come November 11, when the trading floor wakes up, James Hardie will be in and Roku will be out. Pretty neat switcheroo if you ask me. Inside...

NatGold Pulling NATG From MEXC Amid Security Concerns

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Madrigal Faces Legal Scrutiny Amid Whistleblower Claims

The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...

Nemazee Fellowship Advances Clemency and Justice Reform

Nemazee Fellowship: A Catalyst for Change You're probably wondering what's really happening when a couple like Hassan and Nazie Nemazee put their name on a legal fellowship. Skipping the melodrama, it's all about making a dent in the criminal justice system. These two aren't just slapping their name on a plaque—they're throwing real support behind actions that matter....

Havertys Dividend: A Steady Payout Tradition Continues

Another Year, Another Dividend for Havertys Man, talk about a company with a rock-solid habit. Havertys Furniture Companies (NYSE: HVT) just announced its latest cash dividend, cementing a tradition that's been rolling since 1935. They're dropping $0.33 per share on the common stock and $0.31 on the Class A common stock. It's set to hit investors' pockets by December 9,...

IRTC Faces Investigation: Shares Plunge Amid Uncertainty

Securities Trouble on the Horizon: IRTC Takes a Hit Wake up and adjust your seat, folks—iRhythm Technologies (NASDAQ:IRTC) is in the spotlight, and it ain't pretty. Shares nosedived over 30% in a single morning, stirring up quite the murky waters for shareholders. The trigger? A less-than-stellar third-quarter report. The Numbers Don't Lie—Or Do They? Management...